Form 4: Tandem Diabetes Care Executive Susan Morrison Reports Stock Transactions
SEC Form 4 Filing
EVP & Chief Admin. Officer of Tandem Diabetes Care, Susan Morrison, reports acquisition and disposal of company stock and restricted stock units.
Summary
- On May 15, 2024, Susan Morrison, EVP & Chief Admin. Officer of Tandem Diabetes Care, reported transactions involving the company's stock.
- These transactions include the acquisition of 1,360 shares of common stock through the Employee Stock Purchase Plan at a price of $15.64 per share.
- Morrison also acquired shares through the vesting of restricted stock units (RSUs).
- A total of 162, 474, and 6,012 shares were acquired through RSU conversions.
- Shares were withheld to satisfy tax obligations related to the vesting of RSUs, with 47, 136, and 1,720 shares withheld at a price of $47.37.
- Following these transactions, Morrison directly owns 21,556 shares of Tandem Diabetes Care stock.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Positives
- The acquisition of shares through the ESPP demonstrates Morrison's investment in the company's future.
Industry Context
Form 4 filings are standard practice for reporting insider transactions and provide transparency to investors regarding the buying and selling activities of company executives.
Comparison to Industry Standards
- Executive compensation packages, including stock options and RSUs, are common in the medical device industry to align management's interests with those of shareholders.
- Companies like Insulet and Dexcom also utilize similar equity-based compensation plans for their executives.
Stakeholder Impact
- The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
Key Dates
| Date | Description |
|---|---|
| 05/18/2021 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| 05/25/2022 | Date of RSU award pursuant to the 2013 Stock Incentive Plan. |
| 05/25/2023 | Date of RSU award pursuant to the 2023 Long-Term Incentive Plan. |
| 05/15/2024 | Date of stock transactions and RSU vesting. |
| 05/17/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.